The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Antispasmodics Drugs Market At The End Of The 2026–2030 Forecast Period?
The antispasmodics drugs market size has experienced significant expansion over recent years. It is projected to increase from $14.93 billion in 2025 to $16.34 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. Historically, this market’s growth is attributable to the increasing incidence of IBS and stomach cramps, the expanding hospital pharmacy infrastructure, the uptake of oral antispasmodic tablets, enhanced awareness concerning gastrointestinal health, and advancements in drug formulation technologies.
The antispasmodics drugs market is projected to experience robust expansion in the coming years. Its valuation is set to reach $23.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. This expansion during the forecast period is driven by factors such as advancements in precision medicine, the development of injectable and liquid antispasmodics, the proliferation of online pharmacy platforms, an expanding geriatric and pediatric patient population, and the integration of digital health monitoring systems. Defining trends for this period include personalized antispasmodic therapy, advanced drug delivery systems, the increasing prevalence of gastrointestinal disorders, growing adoption of homecare medication, and a rising focus on pediatric and geriatric patients.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9414&type=smp
What Primary Drivers Are Shaping The Development Of The Antispasmodics Drugs Market?
The antispasmodic drug market is anticipated to expand due to a growing elderly population. Individuals aged 65 and above are classified as elderly and frequently experience numerous physical and psychological health problems. Antispasmodic drugs offer benefits to this demographic by helping manage symptoms from conditions causing muscle spasms or cramping, including irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), interstitial cystitis, and uterine cramping. For example, the UK Parliament’s House of Commons Library reported in July 2024 that 12.7 million people in the UK were 65 or older in 2022. This figure is predicted to reach 22.1 million by 2072, making up 27% of the total population. Consequently, the expansion of the elderly demographic will boost the antispasmodic drug market.
What Segment Types Make Up The Antispasmodics Drugs Market?
The antispasmodics drugs market covered in this report is segmented –
1) By Drug: Dicyclomine Hydrochloride, Loperamide Hydrochloride, Other Drugs
2) By Indication: Irritable Bowel Syndrome, Stomach Cramps, Other Indications
3) By Route Of Administration: Oral, Parenteral, Other Modes Of Administrations
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Dicyclomine Hydrochloride: Oral Tablets, Injectable Formulations
2) By Loperamide Hydrochloride: Oral Tablets, Liquid Formulations
3) By Other Drugs: Hyoscine Butylbromide (Scopolamine), Peppermint Oil, Atropine, Other Antispasmodics
Which Market Trends Are Creating New Opportunities In The Antispasmodics Drugs Market?
Prominent companies operating in the antispasmodics drugs market are introducing new products to secure their market position. For example, in January 2023, Lupin Limited, an Indian pharmaceutical company, launched Fesoterodine Fumarate, which received approval from the Food and Drug Administration (FDA), a US-based federal government agency. Fesoterodine fumarate is a generic antispasmodic medication prescribed for certain bladder issues, including overactive bladder and neurogenic detrusor overactivity. This drug, Fesoterodine fumarate, falls under the antispasmodic class and operates by relaxing the bladder muscles. It is offered in the form of extended-release tablets.
Who Are The Key Players Driving Competition In The Antispasmodics Drugs Market?
Major companies operating in the antispasmodics drugs market are Daiichi Sankyo Company Limited, Fresenius Kabi AG, Hikma Pharmaceuticals plc, Johnson & Johnson Services Inc., Pfizer Inc., Shanghai Fosun Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Akorn Inc., Aurobindo Pharma Limited, Lannett Company Inc., Nexus Pharmaceuticals Inc., Actiza Pharmaceutical Private Limited, Blue Cross Laboratories Pvt. Ltd., Dr. Reddy’s Laboratories Ltd., Lexicare Pharma Pvt. Ltd., Solitaire Pharmacia Private Limited, Strides Pharma Science Limited, Wellona Pharma Private Limited, SunGen Pharma LLC, GlaxoSmithKline plc, Novartis AG, Sanofi SA, AstraZeneca plc, Merck & Co. Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Ltd.
Read the full antispasmodics drugs market report here:
https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report
How Does The Antispasmodics Drugs Market Perform Across Major Global Regions?
North America was the largest region in the antispasmodics drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the antispasmodics drugs market report during the forecast period. The regions covered in the antispasmodics drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Antispasmodics Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=9414&type=smp
Browse Through More Reports Similar to the Global Antispasmodics Drugs Market 2026, By The Business Research Company
Antispasmodics Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report
Antiparasitic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
Anticoccidial Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model